北斗星通(002151.SZ):2021年度擬向銀行申請綜合授信額度共計12.9億元
格隆匯3月25日丨北斗星通(002151.SZ)公佈,公司召開第六屆董事會第二次會議,審議通過了《關於預計2021年度申請銀行綜合授信額度的議案》。
同意公司因生產經營需要,於2021年度向銀行申請綜合授信額度共計12.9億元(含2020年已審批額度的展期11億元)。實際授信額度以銀行最終審批為準。
此次授信額度12.9億元審議通過後,公司連續12個月內審批的累計申請銀行授信額度為13.965億元,佔公司最近一期經審計總資產比例為19.59%。
上述綜合授信所涉及的業務協議將於公司發生相關業務時簽署,公司授權董事長周儒欣代表公司簽署上述事項的相關文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.